Sunnybrook

Rewiring the brain: More than $25 million to advance Sunnybrook's Harquail Centre for Neuromodulation

Retrieved on: 
Thursday, June 22, 2023
Sunnybrook, Faculty, Deep brain stimulation, Psychiatry, Partnership, Depression, University, Tic disorder, Education, Internal medicine, Engineering, U of T, Research, DSM-IV codes, Hospital, Parkinson's disease, Patient, Post-traumatic stress disorder, University of Toronto Faculty of Applied Science and Engineering, University of Toronto Faculty of Medicine, Health, ALS, Family, Neurology, Alzheimer's disease, Sunnybrook Health Sciences Centre, Pharmaceutical industry, Medical imaging, Management, Medical device, Medicine, Maurice Harquail, Neuromodulation

The gift will also endow a new Harquail Chair in Neuromodulation to be held by the Harquail Centre's director.

Key Points: 
  • The gift will also endow a new Harquail Chair in Neuromodulation to be held by the Harquail Centre's director.
  • "The Harquail family's generous foundational support established the Harquail Centre as a global leader in brain therapy," said Dr. Nir Lipsman, director of the Harquail Centre for Neuromodulation and associate professor of surgery at U of T, who will be the inaugural Harquail Chair in Neuromodulation.
  • In addition to the Harquail family's investment, Sunnybrook Foundation and U of T have committed $3 million and $1 million respectively in matching funds to the Harquail Centre for Neuromodulation.
  • Deeply interdisciplinary in its approach, the Harquail Centre supports a critical mass of experts in surgery, internal medicine, psychiatry, neurology and other fields.

Brain Cancer Canada Grants Research Funds to Improve Survival Rates for Glioblastoma and Other Gliomas

Retrieved on: 
Thursday, May 25, 2023
Sunnybrook, Canada, Glioblastoma, Prognosis, Research, Brain, Brain tumor, Patient, Neuro, Partnership, Sunnybrook Health Sciences Centre, Medical imaging

TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada, a leading charity in the fight against brain cancer, is delighted to announce a $50,000 research grant to Dr. Amit Singnurkar at Sunnybrook Health Sciences Centre.

Key Points: 
  • TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada, a leading charity in the fight against brain cancer, is delighted to announce a $50,000 research grant to Dr. Amit Singnurkar at Sunnybrook Health Sciences Centre.
  • The grant will support a ground-breaking study to improve the treatment of high-grade gliomas, the most aggressive form of brain cancer.
  • “We are hopeful that this research will make a significant difference in the treatment of high-grade gliomas,” Dr. Singnurkar said.
  • “This research has the potential to be a game-changer in the treatment of high-grade gliomas, such as glioblastoma,” she said.

Veteran support organizations boosted by Legion’s Ontario Command

Retrieved on: 
Thursday, January 26, 2023
Well, Linda, Good Shepherd, Employment, Royal Canadian, Dog, Trauma, Operational Stress Injury, Sunnybrook, World War II, Risk, Case management, Legion, Health care, Service, VTN, Partnership, Veterans Affairs Canada, Mission, Working dog, Organization, Wounded Warrior Project, Dominion, Management, Real estate, Hospital, Animal, Veteran

OTTAWA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- With the newest “Operation Service Dog” puppy recruit standing by, The Royal Canadian Legion’s Ontario Command recently announced a substantial new year’s investment of $1,144,741 in four organizations. Collectively, their goals align with the Legion’s mission of supporting and remembering Canada’s Veterans and their families.

Key Points: 
  • “Their critical work and dedication to help our Veterans is why we’ve made these significant financial donations,” says Derek Moore, Royal Canadian Legion Ontario Command President.
  • Wounded Warriors Canada partnership with Ontario Command: “Operation Service Dog”
    Well-trained service dogs can be life savers for Veterans facing mental health challenges.
  • “In Ontario, it really wouldn’t be possible without the support of Ontario Command and the branches right across this wonderful province of ours,” he says.
  • All projects were funded through Poppy Funds donated in Ontario, except in the case of the Veteran Transition Network, which was funded through Ontario Command Military Service Recognition Book proceeds.

Government of Canada announces the recipients of support from INOVAIT's Focus Fund

Retrieved on: 
Wednesday, January 18, 2023
IGT, University, Sunnybrook, Ageing, Face, Sunnybrook Research Institute, Parliamentary system, Government, Machine learning, The Honourable, Partnership, Growth, Therapy, Patient, Intelligence, Municipal government in Canada, Emergency, Research, Stroke, Pharmaceutical industry, Animal, Medical device, Health, AI, Science

That is why the Government of Canada continues to invest in the health care industry to ensure Canada remains a world leader in medical innovations.

Key Points: 
  • That is why the Government of Canada continues to invest in the health care industry to ensure Canada remains a world leader in medical innovations.
  • Today, Adam van Koeverden, Parliamentary Secretary to the Minister of Health and to the Minister of Sport, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced the 14 recipients of support from INOVAIT's Focus Fund.
  • Thanks to the INOVAIT Focus Fund, we are seeing more jobs, growth and game-changing solutions that will benefit Canada."
  • Today's recipients of Focus Fund support will help position Canada and its industries as world leaders in this sector.

Sunnybrook Health Sciences Centre in Canada selects RayStation: RaySearch Laboratories

Retrieved on: 
Wednesday, September 7, 2022
CEO, EU, Cancer, SEK, Sunnybrook, RaySearch Laboratories, Sale, Ontario Health (agency), Person, CAD, Hospital, Sunnybrook Health Sciences Centre, Patient, Pharmaceutical industry

STOCKHOLM, Sept. 7, 2022 /PRNewswire/ -- Sunnybrook Health Sciences Centre, one of Canada's largest hospitals, offers a highly specialized comprehensive cancer program and treats more than 7,000 cancer patients per year. The center is equipped with 13 linear accelerators. This is the first sale made in Ontario since a Master Purchase Agreement was signed with Ontario Health in the first quarter of 2022.

Key Points: 
  • RaySearch Laboratories AB (publ) announces that Sunnybrook Health Sciences Centre Odette Cancer Centre in Toronto, Canada, has placed an order for RayStation* treatment planning system
    STOCKHOLM, Sept. 7, 2022 /PRNewswire/ --Sunnybrook Health Sciences Centre, one of Canada's largest hospitals, offers a highly specialized comprehensive cancer program and treats more than 7,000 cancer patients per year.
  • This is the first sale made in Ontario since a Master Purchase Agreement was signed with Ontario Health in the first quarter of 2022.
  • Johan Lf, founder and CEO, RaySearch, says: "Canada has one of the world's most advanced cancer care programs.
  • This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.

Children and Families Received Free Dental Care During Sunnybrook Dentistry & Braces-Sponsored Sharing Smiles Day

Retrieved on: 
Monday, June 20, 2022
Time, Dental care, Brace, Chief Dental Officer (Canada), Orthodontics, Dentistry, Parent, Conditional sentence, Pleasure, Pain, Family, Volunteering, Health, Quality of life, Partnership, Adult, Legislation, Patient, Sunnybrook, Dentist, GLOBE, Degenerative disease, Diabetes, Health insurance, Medicaid

Sharing Smiles Day, held on May 22, 2022, provides an opportunity for uninsured or underinsured children and adults to receive dental care and treatments at no cost, including dental exams and cleanings, emergency care, extractions, and restorative care.

Key Points: 
  • Sharing Smiles Day, held on May 22, 2022, provides an opportunity for uninsured or underinsured children and adults to receive dental care and treatments at no cost, including dental exams and cleanings, emergency care, extractions, and restorative care.
  • Three dentists from Sunnybrook Dentistry volunteered their time, Dr. Thomas Sagrera, Dr. Kineshia Roark, and Dr. Cristie Rives were part of 30 dentists who provided free dental services for Sharing Smiles Day.
  • This year 294 team members from Sunnybrook Dentistry and 22 other Benevis partner dental offices participated in Sharing Smiles Day.
  • Sunnybrook Dentistry & Braces is one of Mississippis leaders in Medicaid and affordable dental care for children and their families.

Sunnybrook Dentistry & Braces Supports Sharing Smiles Day – A Free Day of Dental Care for Families in Need

Retrieved on: 
Wednesday, May 4, 2022
Dentist, GLOBE, Dentistry, Degenerative disease, Dental care, MS, Patient, Asthma, Partnership, Sunnybrook, Diabetes, Conditional sentence, Chief Dental Officer (Canada), Health, Quality of life, Â, DDS, Tooth decay, Brace, DMD, VP, Medicaid

Sharing Smiles Day is a volunteer event that provides a free day of dental care to uninsured children and their families.

Key Points: 
  • Sharing Smiles Day is a volunteer event that provides a free day of dental care to uninsured children and their families.
  • This year, volunteer doctors and staff from Sunnybrook Dentistry and its partner dental offices will participate in the free day of dental care for uninsured and underinsured children.
  • Sunnybrook Dentistry & Braces is one of Mississippis leaders in Medicaid and affordable dental care for children and their families.
  • Sunnybrook Dentistry and its doctors are committed to improving lives by providing high-quality dental care in a fun, compassionate environment.

Conavi Medical’s Novasight Hybrid System Now In Use at Sunnybrook Health Sciences Centre

Retrieved on: 
Thursday, April 28, 2022
General Health, Medical Devices, Health, Clinical Trials, Cardiology, Veteran, Volunteering, CEO, Artery, OCT, Patient, Blood, Education, Sunnybrook Health Sciences Centre, Lithotripsy, Canton, Cardiovascular disease, Health Canada, University, Food, Cancer, Ministry, Rehabilitation, Adoption, Heart, MHLW, Physician, Sunnybrook, Research, Program, Sunnybrook Research Institute, IVUS, SRI, Injury, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Medical imaging, Health

Conavi Medical Inc. ( www.conavi.com ), a leader of hybrid imaging guidance for common minimally invasive heart procedures, and Sunnybrook Health Sciences Centre, today announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program.

Key Points: 
  • Conavi Medical Inc. ( www.conavi.com ), a leader of hybrid imaging guidance for common minimally invasive heart procedures, and Sunnybrook Health Sciences Centre, today announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program.
  • The hybrid intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging platform, now called Novasight Hybrid System, was initially invented at Sunnybrook Research Institute (SRI) by Dr. Brian Courtney, a scientist and interventional cardiologist.
  • In fact, its a key part of our strategic plan, said Andy Smith, President and CEO of Sunnybrook Health Sciences Centre.
  • Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration, and regulatory approval for clinical use from Health Canada, and the Ministry of Health, Labor and Welfare (MHLW) in Japan.

Health Care Leaders Gather to Discuss Strategy to Integrate Internationally Educated Health Professionals to Help Meet Ontario’s Health Care Needs

Retrieved on: 
Monday, April 11, 2022
Long-term care, Organization, Nursing, Sunnybrook Health Sciences Centre, RN, Hospital, Woman, MPH, Statistics, CEO, Health, Refugee, Workforce, Government, Organization development, Ontario Health (agency), Database, Hope, Statistics Canada, Health education, Human resources, Licensure, GLOBE, WES, Sunnybrook, World Education Services, PSW, CCPA, Education, Workplace, We Global, Patient, Medicine, Management, MD

This is the first time these stakeholders will assemble to share their vision of how to rebuild Ontarios health workforce with the deliberate inclusion of internationally educated health professionals (IEHPs).

Key Points: 
  • This is the first time these stakeholders will assemble to share their vision of how to rebuild Ontarios health workforce with the deliberate inclusion of internationally educated health professionals (IEHPs).
  • Yet the province has a database of over 8,000 internationally educated health professionals who registered with Ontario Health between 2017 and 2021.
  • This database includes internationally trained nurses, doctors, medical lab technicians, respiratory therapists, and other health professionals who could be supporting our health care system and caring for patients.
  • And we certainly cannot afford to lose their skills and experience when our health care system needs health professionals.

GBM AGILE Opens to Paxalisib in Canada

Retrieved on: 
Monday, November 29, 2021
Patient, Volunteering, McGill University, University, ASX, GBM, Global Coalition Against Pneumonia, MGMT, Cancer, DIPG, Leadership, Temozolomide, Education, Orphan, VEGFR3, Glioblastoma, Sunnybrook, Survival, Twitter, Research, Lead, NASDAQ, Bayer, Sunnybrook Health Sciences Centre, FDA, Injury, PI3K, Brain, Therapy, Multimedia, Cardiovascular disease, KZIA, Medicine, Management, Pharmaceutical industry, Medical imaging, Health insurance

The opening of McGill University to the paxalisib arm represents the commencement of clinical trial activity for paxalisib in Canada.

Key Points: 
  • The opening of McGill University to the paxalisib arm represents the commencement of clinical trial activity for paxalisib in Canada.
  • Kazia expects GBM AGILE to serve as the pivotal study for registration in key markets, including Canada.
  • The total data set for paxalisib will therefore likely include up to approximately 450 patients from GBM AGILE.
  • Licensed from Genentech in late 2016, paxalisib commenced recruitment to GBM AGILE, a pivotal study in glioblastoma, in January 2021.